Contrafect Corp (CFRX): Correct. We were just discussing OTC vs...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	656
Posts	19213
Boards Moderated	4
Alias Born	07/03/2011

subslover

Re: NorthTrail post# 564

Friday, 06/09/2023 8:35:24 AM

Friday, June 09, 2023 8:35:24 AM

Correct. We were just discussing OTC vs NASDAQ

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CFRX News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:24:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:41:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:30:55 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/03/2023 09:08:09 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/03/2023 04:16:01 AM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/30/2023 09:24:34 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/24/2023 08:06:07 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2023 08:05:56 PM
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study • GlobeNewswire Inc. • 10/16/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 03:15:52 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 12:00:18 PM
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development • GlobeNewswire Inc. • 09/19/2023 12:30:00 PM
ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370 • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/14/2023 08:05:49 PM
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023 • GlobeNewswire Inc. • 08/28/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:10:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:18:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:10:59 PM
ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2023 12:30:00 PM

More CFRX News

InvestorsHub NewsWire

Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM

Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover